CVS Health Reports First Quarter Results; Confirms 2017 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
CVS Health (CVS) PT Raised to $88 at Evercore ISI; Model Bent Not Broken
May 2, 2017 12:27 PM EDTEvercore ISI raised its price target on CVS Health (NYSE: CVS) to $88.00 (from $87.00) while maintaining a Outperform rating following Q1 results.
Analyst Ross Muken believes shares are down today amid a "buyers strike" and bears who are feeling more emboldened. Meanwhile,... More
CVS Health (CVS) Tops Q1 EPS by 7c; Confirms Guidance
May 2, 2017 6:57 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $1.17, $0.07 better than the analyst estimate of $1.10. Revenue for the quarter came in at $44.5 billion versus the consensus estimate of $44.2 billion.
Net revenues increased 3.0% to $44.5 billionGAAP diluted EPS from continuing operations of $0.92; Adjusted EPS of... More